Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis
Clinical trial NCT05969223 · COMPLETED
Trial details
- NCT number
- NCT05969223
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2025-01-22
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.